NO20022692L - Terapeutiske midler - Google Patents

Terapeutiske midler

Info

Publication number
NO20022692L
NO20022692L NO20022692A NO20022692A NO20022692L NO 20022692 L NO20022692 L NO 20022692L NO 20022692 A NO20022692 A NO 20022692A NO 20022692 A NO20022692 A NO 20022692A NO 20022692 L NO20022692 L NO 20022692L
Authority
NO
Norway
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Application number
NO20022692A
Other languages
English (en)
Other versions
NO20022692D0 (no
NO332259B1 (no
Inventor
Robert Arthur Sherry
Tracey Jane Rhoades
Frederick Raymond Higton
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9929077.7A external-priority patent/GB9929077D0/en
Priority claimed from GBGB9929078.5A external-priority patent/GB9929078D0/en
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of NO20022692D0 publication Critical patent/NO20022692D0/no
Publication of NO20022692L publication Critical patent/NO20022692L/no
Publication of NO332259B1 publication Critical patent/NO332259B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
NO20022692A 1999-12-09 2002-06-06 Sammenpresset tablettpreparat, fremgangsmate for fremstilling av slike samt slike preparater for behandling av sykdom NO332259B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9929077.7A GB9929077D0 (en) 1999-12-09 1999-12-09 Therapeutic agents
GBGB9929078.5A GB9929078D0 (en) 1999-12-09 1999-12-09 Therapeutic agents
PCT/EP2000/012193 WO2001041733A2 (en) 1999-12-09 2000-11-30 Compressed tablet composition comprising a nsaid

Publications (3)

Publication Number Publication Date
NO20022692D0 NO20022692D0 (no) 2002-06-06
NO20022692L true NO20022692L (no) 2002-08-07
NO332259B1 NO332259B1 (no) 2012-08-13

Family

ID=26316111

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022692A NO332259B1 (no) 1999-12-09 2002-06-06 Sammenpresset tablettpreparat, fremgangsmate for fremstilling av slike samt slike preparater for behandling av sykdom

Country Status (27)

Country Link
US (1) US8124124B2 (no)
EP (1) EP1235558B1 (no)
JP (1) JP4040878B2 (no)
KR (1) KR20020082464A (no)
CN (1) CN100346774C (no)
AR (1) AR026917A1 (no)
AT (1) ATE324868T1 (no)
AU (1) AU776308B2 (no)
BG (1) BG66007B1 (no)
BR (1) BR0016236A (no)
CA (1) CA2393585C (no)
CY (1) CY1106136T1 (no)
CZ (1) CZ300558B6 (no)
DE (1) DE60027761T2 (no)
DK (1) DK1235558T3 (no)
ES (1) ES2263510T3 (no)
HK (1) HK1046644B (no)
HU (1) HU227045B1 (no)
IL (2) IL150030A0 (no)
MX (1) MXPA02005663A (no)
NO (1) NO332259B1 (no)
NZ (1) NZ519485A (no)
PL (1) PL201223B1 (no)
PT (1) PT1235558E (no)
RU (1) RU2246294C2 (no)
SK (1) SK285706B6 (no)
WO (1) WO2001041733A2 (no)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0113839D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113843D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
BR0307516A (pt) * 2002-02-01 2004-12-07 Pfizer Prod Inc Formas de dosagem de liberação imediata contendo dispersões de uma droga sólida
GB0209265D0 (en) 2002-04-23 2002-06-05 Novartis Ag Organic compounds
GB0423103D0 (en) * 2004-10-19 2004-11-17 Boots Healthcare Int Ltd Therapeutic agents
EP1845949B1 (en) * 2005-02-03 2008-05-21 Nycomed Pharma AS Melt granulation of a composition containing a calcium-containing compound
DE102005037630A1 (de) 2005-08-09 2007-02-15 Glatt Gmbh Verfahren zur Herstellung von Teilchen aus pharmazeutischen Substanzen, Teilchen aus pharmazeutischen Substanzen sowie deren Verwendung
GB0519350D0 (en) * 2005-09-22 2005-11-02 Boots Healthcare Int Ltd Therapeutic agents
AU2006325658B2 (en) * 2005-12-16 2010-04-08 Hanmi Science Co., Ltd. Solid dispersion comprising an active ingredient having a low melting point and tablet for oral administration comprising same
DE602006018467D1 (de) * 2006-09-28 2011-01-05 Losan Pharma Gmbh Schnell lösliche Formulierung von nichtsteroidalen Antiphlogistika
GB2447898B (en) * 2007-03-24 2011-08-17 Reckitt Benckiser Healthcare A tablet having improved stability with at least two actives
DE102008048729A1 (de) * 2008-09-24 2010-03-25 Add Technologies Ltd Advanced Drug Delivery Multipartikuläre Tabletten und Verfahren zur deren Herstellung
US8662705B2 (en) 2010-03-30 2014-03-04 Virwall Systems, Inc. Flexible ultraviolet LED sanitizing apparatus
US20130108699A1 (en) * 2010-04-26 2013-05-02 Jose Antonio Matji Tuduri Highly dispersible granulate for the preparation of formulations of high dosage active substances and procedure for obtaining high dosage active substances thereof
JP5750856B2 (ja) * 2010-10-04 2015-07-22 ライオン株式会社 固形医薬組成物及び医薬製剤
JP5974469B2 (ja) * 2010-12-24 2016-08-23 ライオン株式会社 錠剤の製造方法
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)
EP2793853B1 (en) * 2011-12-23 2015-12-16 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Pharmaceutical formulations of flurbiprofen and glucosamin
EP2704696A1 (en) 2012-03-26 2014-03-12 Glatt AG Taste-masked ibuprofen granules
WO2014078435A1 (en) 2012-11-14 2014-05-22 W. R. Grace & Co.-Conn. Compositions containing a biologically active material and a non-ordered inorganic oxide
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
EP2886107A1 (en) * 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
CZ20131023A3 (cs) * 2013-12-18 2014-08-27 Technická univerzita v Liberci Způsob rozvádění příze při jejím navíjení na cívku uloženou v navíjecím ústrojí pracovního místa textilního stroje a zařízení k jeho provádění
EA201891873A1 (ru) 2014-07-02 2019-04-30 Обсева Са Кристаллический о-метилоксим (3z,5s)-5-(гидроксиметил)-1-[(2'-метил-1,1'-бифенил-4-ил)карбонил]пирролидин-3-он, полезный в способах лечения состояний, связанных с активностью ot-r
US20190022013A1 (en) * 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
BE1023057B1 (nl) * 2016-06-06 2016-11-16 Nordic Specialty Pharma Bvba Ibuprofen tablet

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56120616A (en) * 1980-02-27 1981-09-22 Kaken Pharmaceut Co Ltd Ibuprofen-containing granule, its preparation, and internal medicine comprising it
US4609675A (en) * 1984-08-17 1986-09-02 The Upjohn Company Stable, high dose, high bulk density ibuprofen granulations for tablet and capsule manufacturing
US5240712A (en) * 1987-07-17 1993-08-31 The Boots Company Plc Therapeutic agents
SE463541B (sv) * 1987-08-31 1990-12-10 Lejus Medical Ab Granulaer produkt oeverdragen av en smaelta av sig sjaelv samt foerfarande foer dess framstaellning
DE3833448A1 (de) * 1988-10-01 1990-04-12 Hoechst Ag Verfahren zur gewinnung von ibuprofen fuer die direkttablettierung
JPH05506011A (ja) 1990-04-11 1993-09-02 ジ・アップジョン・カンパニー 流動床コーティングによるイブプロフェンの味覚マスキング
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
DK138592D0 (da) * 1992-11-17 1992-11-17 Nycomed Dak As Tabletter
AT401871B (de) * 1994-01-28 1996-12-27 Gebro Broschek Gmbh Verfahren zur herstellung von s(+)-ibuprofen- partikeln mit verbesserten fliesseigenschaften und deren verwendung zur arzneimittelherstellung
DE4418837A1 (de) * 1994-05-30 1995-12-07 Bayer Ag Thermisches Granulierverfahren
GB9702392D0 (en) 1997-02-06 1997-03-26 Boots Co Plc Therapeutic agents
DE19721467A1 (de) * 1997-05-22 1998-11-26 Basf Ag Verfahren zur Herstellung kleinteiliger Zubereitungen biologisch aktiver Stoffe
GB9710521D0 (en) 1997-05-22 1997-07-16 Boots Co Plc Process
CA2214895C (en) * 1997-09-19 1999-04-20 Bernard Charles Sherman Improved pharmaceutical composition comprising fenofibrate
IE980115A1 (en) * 1998-02-16 2000-02-09 Biovail Internat Ltd Solubilizing delivery systems and method of manufacture

Also Published As

Publication number Publication date
CN1433300A (zh) 2003-07-30
CA2393585A1 (en) 2001-06-14
JP4040878B2 (ja) 2008-01-30
IL150030A (en) 2008-06-05
DE60027761T2 (de) 2007-01-25
SK8022002A3 (en) 2003-07-01
JP2003516341A (ja) 2003-05-13
PL355491A1 (en) 2004-05-04
DE60027761D1 (de) 2006-06-08
ES2263510T3 (es) 2006-12-16
AR026917A1 (es) 2003-03-05
HUP0203553A2 (hu) 2004-05-28
CZ300558B6 (cs) 2009-06-17
MXPA02005663A (es) 2002-09-02
US8124124B2 (en) 2012-02-28
CZ20021971A3 (cs) 2002-11-13
HU227045B1 (en) 2010-05-28
HK1046644B (zh) 2006-11-10
AU2004231245A1 (en) 2004-12-23
EP1235558B1 (en) 2006-05-03
AU776308B2 (en) 2004-09-02
CY1106136T1 (el) 2011-06-08
NO20022692D0 (no) 2002-06-06
NZ519485A (en) 2004-02-27
WO2001041733A3 (en) 2001-11-15
HK1046644A1 (en) 2003-01-24
AU3006001A (en) 2001-06-18
PL201223B1 (pl) 2009-03-31
HUP0203553A3 (en) 2004-06-28
CA2393585C (en) 2007-07-03
PT1235558E (pt) 2006-09-29
RU2246294C2 (ru) 2005-02-20
BR0016236A (pt) 2002-12-24
SK285706B6 (sk) 2007-06-07
US20030203026A1 (en) 2003-10-30
IL150030A0 (en) 2002-12-01
RU2002118210A (ru) 2004-02-20
ATE324868T1 (de) 2006-06-15
WO2001041733A2 (en) 2001-06-14
CN100346774C (zh) 2007-11-07
NO332259B1 (no) 2012-08-13
DK1235558T3 (da) 2006-10-09
EP1235558A2 (en) 2002-09-04
BG106839A (bg) 2003-03-31
BG66007B1 (bg) 2010-10-29
KR20020082464A (ko) 2002-10-31

Similar Documents

Publication Publication Date Title
DK1637127T3 (da) Terapeutisk mikroskum
PT1235558E (pt) Agentes terapeuticos
NO20021400D0 (no) Terapeutiske konazolinderivater
DE69924365D1 (de) Massagegerät
ID27841A (id) Turunan-turunan biaril terapeutik
ID26056A (id) Popok sekali pakai
ID26389A (id) Popok sekali pakai
ATA51899A (de) Handstempel
NO20014490D0 (no) Medisinske blandinger
LU91418I2 (fr) Yondelis-trabectedin
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
ID25571A (id) Popok sekali pakai
ID24782A (id) Popok sekali pakai
PT1178981E (pt) 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos
DE69916133D1 (de) Elektro-neuro-adaptiver stimulator
NO20021976L (no) Selektiv leverterapi
ITMI991895A0 (it) Depigmentanti cutanei
NO20016301D0 (no) Terapeutiske midler
ATE269311T1 (de) Benzoylpyridazine
DE29900728U1 (de) Hand-Massagegerät
ATA111699A (de) Rechenhilfe
NO20014850D0 (no) CML-terapi
DE29904973U1 (de) Baueinheit
ATA732000A (de) Kachelofen

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees